§ Funding Round
Series B funding round for Amolyt Pharma raising $80M in September 2021
Series B funding round for Amolyt Pharma raising $80M in September 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Domain Associates | — | — |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Angel | vincent brichard | |
| Angel | raphael wisniewski | |
| Organization | — | |
| Organization | — | |
Credit Agricole Creation | — | — |
| Organization | — | |
LSP | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$305.5M
Top Valuation
-
Amolyt Pharma raised $80M in a Series B round.
The round was announced on 09/01/21.
The round was led by raphael wisniewski, sectoral asset management.
